Citigroup
OACC

Citigroup’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Citigroup’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Hold
45,000
– – ﹤0.01% 3919
2026
Q1 		$478K Hold
45,000
– – ﹤0.01% 3574
2025
Q4 		$478K Sell
45,000
-5,900
-12% -$62.4K ﹤0.01% 3592
2025
Q3 		$533K Buy
+50,900
New +$532K ﹤0.01% 3539

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup's OACC Position: Q2 2026 in Review

Citigroup held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 45,000 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

Citigroup first reported a position in OACC in Q3 2025 and has held it in 4 quarters since. The position peaked at $533K in Q3 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Citigroup held 45,000 shares of Oaktree Acquisition Corp III Life Sciences worth $482K as of Q2 2026.
  • Citigroup left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3919 holding.
  • Citigroup first reported a position in Oaktree Acquisition Corp III Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Citigroup's Oaktree Acquisition Corp III Life Sciences position peaked at $533K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.